Inclusion Criteria:

1. Informed Consent

2. Locally confined, stage T1a, T2a or T2b prostate cancer

3. Aged 40-65 and judged by the study doctor to be a suitable candidate for a radical
prostatectomy.

4. Serum prostate specific antigen equal to or less than 10mg/ml

5. Histologically confirmed adenocarcinoma of the prostate

6. Gleason score equal to or less than 7

7. Life expectancy of greater than 10 years.

8. Prostate size on TRUS measurement less than 40 grams

Exclusion Criteria:

1. Patients who have undergone prior hormone therapy.

2. Patients with a previous transurethral resectioning of the prostate (TURP)

3. History of other cancers other than basal cell carcinoma.

4. Patients with any prior abdominal surgery.

5. Any condition, or history of illness or surgery than, in the opinion of the
investigator, might confound the results of the study or pose additional risk to the
patient (eg significant cardiovascular conditions)

6. Patients with a large median lobe of the prostate. -

Exclusion Criteria:

-